Want to see JP:6092 full AI Analyst Report?
EnBio Holdings, Inc. (6092) Financial Statements
EnBio Holdings, Inc. Financial Overview
EnBio Holdings, Inc.'s market cap is currently $6.24B. The company's EPS TTM is $13.61; its P/E ratio is 11.20; and it has a dividend yield of 1.18%. EnBio Holdings, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 26 | Mar 25 | Mar 24 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.67B | $ 12.63B | $ 9.58B | $ 8.12B | $ 8.99B |
| Gross Profit | $ 2.65B | $ 3.69B | $ 2.48B | $ 2.76B | $ 2.43B |
| Operating Income | $ 847.76M | $ 1.62B | $ 816.22M | $ 1.36B | $ 1.24B |
| EBITDA | $ 1.35B | $ 2.16B | $ 1.25B | $ 1.76B | $ 1.59B |
| Net Income | $ 452.69M | $ 265.00M | $ 708.76M | $ 812.06M | $ 654.06M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.29B | $ 4.04B | $ 3.60B | $ 2.83B | $ 2.37B |
| Total Assets | $ 21.20B | $ 22.85B | $ 19.31B | $ 17.35B | $ 16.37B |
| Total Debt | $ 10.10B | $ 10.65B | $ 8.62B | $ 8.90B | $ 8.58B |
| Net Debt | $ 6.81B | $ 6.62B | $ 5.02B | $ 6.07B | $ 6.21B |
| Total Liabilities | $ 11.96B | $ 13.52B | $ 10.72B | $ 10.49B | $ 10.40B |
| Stockholders' Equity | $ 9.14B | $ 9.25B | $ 8.49B | $ 6.79B | $ 5.89B |
| Cash Flow | |||||
| Free Cash Flow | $ -1.44B | $ 119.00M | $ 584.36M | $ 826.37M | $ 1.25B |
| Operating Cash Flow | $ 21.92M | $ 1.17B | $ 1.66B | $ 1.99B | $ 2.41B |
| Investing Cash Flow | $ -1.60B | $ -891.00M | $ -1.58B | $ -1.77B | $ -1.48B |
| Financing Cash Flow | $ 1.27B | $ 460.00M | $ 638.92M | $ 240.73M | $ -534.92M |
Currency in JPY